stockportfolio.pro
Abbott Laboratories Total Debt 2007–2025
Abbott Laboratories (ABT) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings. Compound growth +0.7%/yr over 18 years.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $12.93B | -8.5% |
| FY 2024 | $14.13B | -3.8% |
| FY 2023 | $14.68B | -12.5% |
| FY 2022 | $16.77B | -7.1% |
| FY 2021 | $18.05B | -3.7% |
| FY 2020 | $18.75B | +3.4% |
| FY 2019 | $18.14B | -7.3% |
| FY 2018 | $19.57B | -29.9% |
| FY 2017 | $27.92B | +26.9% |
| FY 2016 | $22.01B | +144.5% |
| FY 2015 | $9.00B | +15.0% |
| FY 2014 | $7.83B | +19.3% |
| FY 2013 | $6.56B | -68.0% |
| FY 2012 | $20.48B | +32.8% |
| FY 2011 | $15.41B | -18.5% |
| FY 2010 | $18.92B | +15.0% |
| FY 2009 | $16.46B | +43.8% |
| FY 2008 | $11.45B | +1.1% |
| FY 2007 | $11.32B | — |
Source: Abbott Laboratories SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for Abbott Laboratories
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbott Laboratories — frequently asked questions
What is Abbott Laboratories's total debt (short- plus long-term borrowings)?
Abbott Laboratories (ABT) reported total debt (short- plus long-term borrowings) of $12.93B for fiscal year 2025, per its SEC filings.
How has Abbott Laboratories's total debt (short- plus long-term borrowings) changed over time?
Between fiscal 2007 and 2025, ABT's total debt (short- plus long-term borrowings) grew at roughly 0.7% per year (compound annual rate), from $11.32B to $12.93B.
Where does this data come from?
Figures are computed from Abbott Laboratories's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.